Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Polyarticular or systemic juvenile idiopathic arthritis,~* Growth velocity below the 25th percentile and or short stature ,~* Treatment with glucocorticoids for at least the previous 6 months before inclusion,~* Prepubertal stage,~* Bone age below 10 in girls and 12 in boys,~* Growth hormone levels after stimulation with clonidine or arginine above 10 ng/ml~Exclusion Criteria:~* Previous treatment with growth hormone,~* Endocrinopathy,~* Additional chronic disease beside juvenile idiopathic arthritis,~* Malignant disase,~* Chromosomal aberration or othe syndromal disease,~* Previous treatment with Oxandrolone,~* Small for gestational age,~* Elevated fasting glucose level

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).